 | Esperion Therapeutics (NASDAQ:ESPR) Stock Rating Lowered by Bank of America
marketbeat.com - January 15 at 8:34 AM |
| Esperion Therapeutics (NASDAQ:ESPR) Upgraded to "Outperform" by Credit Suisse Group
marketbeat.com - November 10 at 8:57 AM |
| Esperion Therapeutics (NASDAQ:ESPR) Downgraded by BidaskClub
marketbeat.com - October 23 at 3:30 AM |
| Esperion Therapeutics (NASDAQ:ESPR) Receives New Coverage from Analysts at JPMorgan Chase & Co.
marketbeat.com - September 29 at 7:30 AM |
| Esperion Therapeutics (NASDAQ:ESPR) PT Lowered to $55.00
marketbeat.com - August 17 at 11:56 AM |
 | Esperion Therapeutics (NASDAQ:ESPR) Cut to Neutral at Bank of America
americanbankingnews.com - January 15 at 4:02 PM |
 | Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down
finance.yahoo.com - January 14 at 7:54 PM |
| Esperion Therapeutics (NASDAQ:ESPR) Trading Down 11.1%
americanbankingnews.com - January 13 at 11:18 PM |
 | Notable Wednesday Option Activity: ESPR, CFR, DD
nasdaq.com - January 13 at 6:18 PM |
| Why Esperion Therapeutics Stock Is Falling Today
finance.yahoo.com - January 13 at 6:18 PM |
|
| Investors Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR)
americanbankingnews.com - January 13 at 12:12 PM |
| ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program
finance.yahoo.com - January 13 at 8:12 AM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Rating of "Buy" by Brokerages
americanbankingnews.com - January 6 at 10:48 AM |
| Esperion Therapeutics (NASDAQ:ESPR) Shares Up 6.6%
americanbankingnews.com - January 4 at 9:14 PM |
| Esperion to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 21 at 1:26 PM |
| Need To Know: Esperion Therapeutics, Inc. (NASDAQ:ESPR) Insiders Have Been Buying Shares
finance.yahoo.com - December 19 at 1:58 PM |
| Is ESPR A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 6:03 PM |
 | Why BioLine, Esperion And More Are Moving Today
benzinga.com - December 16 at 1:03 PM |
| First-in-class cholesterol-lowering treatment NILEMDO® * (bempedoic acid) tablet and its combination with ezetimibe NUSTENDI® * (bempedoic acid and ezetimibe) tablet approved in Switzerland
finance.yahoo.com - December 16 at 8:02 AM |
| ESPERION Appoints Sheldon Koenig as Chief Operating Officer
finance.yahoo.com - December 15 at 12:00 PM |
| Why Is Esperion Therapeutics (ESPR) Up 17.5% Since Last Earnings Report?
finance.yahoo.com - December 2 at 4:04 PM |
| Should Value Investors Buy Esperion Therapeutics (ESPR) Stock?
finance.yahoo.com - December 2 at 4:04 PM |
| NEXLETOL® (bempedoic acid) Tablets Highlighted at AHA 2020 with Presentations of Analyses Demonstrating Significant Low-Density Lipoprotein Cholesterol (LDL-C) Lowering vs. Placebo in Phase 3 Study Subgroups
finance.yahoo.com - November 13 at 12:09 PM |
| Esperion Announces Pricing of Offering of $250.0 Million of Convertible Senior Subordinated Notes
finance.yahoo.com - November 12 at 8:07 AM |
| Esperion Announces Private Offering of $200.0 Million of Convertible Senior Subordinated Notes
finance.yahoo.com - November 10 at 6:13 PM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR) Just Reported And Analysts Have Been Cutting Their Estimates
nasdaq.com - November 4 at 9:24 AM |
| Esperion Therapeutics, Inc. (NASDAQ:ESPR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 4 at 9:24 AM |
| Esperion (ESPR) Q3 Earnings Top, Coronavirus Woes Linger
finance.yahoo.com - November 3 at 1:40 PM |
| Esperion Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 2:52 PM |
 | Esperion Therapeutics Q3 2020 Earnings Preview
seekingalpha.com - November 1 at 5:59 PM |
|
| Esperion to Participate in Three Upcoming Virtual Investor Conferences
finance.yahoo.com - October 27 at 12:38 PM |
| Earnings Preview: Esperion Therapeutics (ESPR) Q3 Earnings Expected to Decline
finance.yahoo.com - October 26 at 2:31 PM |
| Esperion to Report Third Quarter 2020 Financial Results November 2, 2020
finance.yahoo.com - October 19 at 10:41 AM |
 | Esperion Therapeutics, Inc.'s (NASDAQ:ESPR) Intrinsic Value Is Potentially 33% Above Its Share Price
uk.finance.yahoo.com - September 28 at 7:31 PM |
| Esperion Therapeutics, Inc.'s (NASDAQ:ESPR) Intrinsic Value Is Potentially 33% Above Its Share Price
finance.yahoo.com - September 22 at 1:47 PM |
| Esperion to Participate in Two Upcoming Virtual Investor Conferences
finance.yahoo.com - September 2 at 2:10 PM |
 | Esperion Announces Two Data Presentations of NEXLETOL(R) (bempedoic acid) Tablet at the ESC Congress 2020
marketwatch.com - August 26 at 12:05 PM |
| Esperion (ESPR) Q2 Earnings Top, Drug Sales Hurt by Coronavirus
finance.yahoo.com - August 11 at 5:15 PM |
| Esperion Therapeutics, Inc. (ESPR) CEO Tim Mayleben on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 4:24 AM |
| Esperion Therapeutics Inc (ESPR) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 11 at 4:24 AM |
| Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update
finance.yahoo.com - August 10 at 6:23 PM |
| Esperion Therapeutics (ESPR) Beats Q2 Earnings Estimates
finance.yahoo.com - August 10 at 6:23 PM |
| Esperion Therapeutics Q2 2020 Earnings Preview
seekingalpha.com - August 9 at 7:42 PM |
| Were Hedge Funds Right About Betting On Esperion Therapeutics (ESPR)?
finance.yahoo.com - August 7 at 10:46 AM |
| Esperion Therapeutics'(NASDAQ:ESPR) Share Price Is Down 42% Over The Past Five Years.
finance.yahoo.com - August 6 at 2:01 PM |
| Esperion Therapeutics'(NASDAQ:ESPR) Share Price Is Down 42% Over The Past Five Years.
finance.yahoo.com - August 6 at 2:01 PM |
| Esperion to Report Second Quarter 2020 Financial Results August 10, 2020
finance.yahoo.com - August 3 at 8:44 AM |
| ESPR Aug 2020 40.000 call
uk.finance.yahoo.com - July 26 at 5:42 PM |
| Esperion Therapeutics Becomes Oversold
www.nasdaq.com - July 24 at 6:31 PM |
| Esperion Therapeutics Scores Relative Strength Rating Upgrade; Hits Key Threshold
finance.yahoo.com - July 16 at 7:26 PM |
| Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Efficacy Analysis from the Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL® (bempedoic acid) Tablets
finance.yahoo.com - July 1 at 1:45 PM |
| Esperion Therapeutics: An Easy Double, Maybe A Lot More
seekingalpha.com - June 26 at 4:26 AM |
| Esperion Therapeutics, Inc. (ESPR): Hedge Funds Are Getting Bullish
finance.yahoo.com - June 23 at 1:41 PM |
| Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) Tablets Presented at the American Diabetes Association 80th Scientific Sessions
finance.yahoo.com - June 14 at 10:48 AM |
| Edited Transcript of ESPR earnings conference call or presentation 6-May-20 8:30pm GMT
finance.yahoo.com - June 12 at 3:08 PM |
